References
- Antman K, Chang Y. Kaposi’s sarcoma. N Engl J Med. 2000;342(14):1027–1038. doi:10.1056/NEJM200004063421407
- La Ferla L, Pinzone MR, Nunnari G, et al. Kaposi’ s sarcoma in HIV-positive patients: the state of art in the HAART-era. Eur Rev Med Pharmacol Sci. 2013;17(17):2354–2365.
- Lager I, Altini M, Coleman H, Ali H. Oral Kaposi’s sarcoma: a clinicopathologic study from South Africa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96(6):701–710. doi:10.1016/S1079-2104(03)00370-6
- Bunn BK, Carvalho Mde V, Louw M, Vargas PA, van Heerden WF. Microscopic diversity in oral Kaposi sarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(2):241–248. doi:10.1016/j.oooo.2012.11.009
- Pantanowitz L, Khammissa R, Lemmer J, Feller L. Oral HIV-associated Kaposi sarcoma. J Oral Pathol Med. 2013;42(3):201–207. doi:10.1111/j.1600-0714.2012.01180.x
- Pantanowitz L, Otis CN, Dezube BJ. Immunohistochemistry in Kaposi’s sarcoma. Clin Exp Dermatol. 2010;35(1):68–72. doi:10.1111/j.1365-2230.2009.03707.x
- Karass M, Grossniklaus E, Seoud T, Jain S, Goldstein DA. Kaposi sarcoma inflammatory cytokine syndrome (KICS): a rare but potentially treatable condition. Oncologist. 2017;22(5):623–625. doi:10.1634/theoncologist.2016-0237
- Fatahzadeh M. Kaposi sarcoma: review and medical management update. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113(1):2–16. doi:10.1016/j.tripleo.2011.05.011
- Fatahzadeh M, Schwartz RA. Oral Kaposi’s sarcoma: a review and update. Int J Dermatol. 2013;52(6):666–672. doi:10.1111/j.1365-4632.2012.05758.x
- Reid E, Suneja G, Ambinder RF, et al. AIDS-related Kaposi sarcoma, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(2):171–189. doi:10.6004/jnccn.2019.0008